GERON CORP Operating Expenses
GERON CORP (GERN) reported Operating Expenses of $69.98 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-05
- GERON CORP operating expenses for the quarter ending 2026-06-30 was $69.98M, a 13.80% increase year-over-year.
- GERON CORP operating expenses for the quarter ending 2026-03-31 was $51.68M, a 8.22% decline year-over-year.
- GERON CORP operating expenses for the quarter ending 2025-12-31 was $73.56M, a 8.83% increase year-over-year.
- GERON CORP operating expenses for the quarter ending 2025-09-30 was $61.11M, a 8.19% increase year-over-year.
- GERON CORP operating expenses for fiscal 2025 was $252.47M, a 0.69% increase from fiscal 2024.
- GERON CORP operating expenses for fiscal 2024 was $250.73M, a 29.12% increase from fiscal 2023.
- GERON CORP operating expenses for fiscal 2023 was $194.18M, a 39.55% increase from fiscal 2022.
- GERON CORP operating expenses for fiscal 2022 was $139.15M, a 20.59% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $69.98M 10-Q · filed 2026-08-05 | $121.66M 10-Q · filed 2026-08-05 | $195.21M derived: sum of 3 quarters · filed 2026-08-05 | $256.32M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $51.68M 10-Q · filed 2026-05-06 | $125.23M derived: sum of 2 quarters · filed 2026-05-06 | $186.35M derived: sum of 3 quarters · filed 2026-05-06 | $247.84M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $73.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $134.67M derived: sum of 2 quarters · filed 2026-03-02 | $196.16M derived: sum of 3 quarters · filed 2026-08-05 | $252.47M 10-K · filed 2026-03-02 |
| 2025-09-30 | $61.11M 10-Q · filed 2025-11-07 | $122.60M derived: sum of 2 quarters · filed 2026-08-05 | $178.91M 10-Q · filed 2025-11-07 | $246.50M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $61.49M 10-Q · filed 2026-08-05 | $117.80M 10-Q · filed 2026-08-05 | $185.38M derived: sum of 3 quarters · filed 2026-08-05 | $241.87M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $56.31M 10-Q · filed 2026-05-06 | $123.89M derived: sum of 2 quarters · filed 2026-05-06 | $180.38M derived: sum of 3 quarters · filed 2026-05-06 | $250.59M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $67.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $124.07M derived: sum of 2 quarters · filed 2026-03-02 | $194.29M derived: sum of 3 quarters · filed 2026-03-02 | $250.73M 10-K · filed 2026-03-02 |
| 2024-09-30 | $56.49M 10-Q · filed 2025-11-07 | $126.70M derived: sum of 2 quarters · filed 2025-11-07 | $183.14M 10-Q · filed 2025-11-07 | $237.45M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | $70.22M 10-Q · filed 2025-08-06 | $126.65M 10-Q · filed 2025-08-06 | $180.97M derived: sum of 3 quarters · filed 2026-03-02 | $228.74M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | $56.44M 10-Q · filed 2025-05-07 | $110.75M derived: sum of 2 quarters · filed 2026-03-02 | $158.53M derived: sum of 3 quarters · filed 2026-03-02 | $210.51M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | $54.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $102.09M derived: sum of 2 quarters · filed 2026-03-02 | $154.07M derived: sum of 3 quarters · filed 2026-03-02 | $194.18M 10-K · filed 2026-03-02 |
| 2023-09-30 | $47.78M 10-Q · filed 2024-11-07 | $99.76M derived: sum of 2 quarters · filed 2024-11-07 | $139.87M 10-Q · filed 2024-11-07 | $181.92M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $51.98M 10-Q · filed 2024-08-08 | $92.09M 10-Q · filed 2024-08-08 | $134.15M derived: sum of 3 quarters · filed 2025-02-27 | $174.39M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $40.11M 10-Q · filed 2024-05-02 | $82.17M derived: sum of 2 quarters · filed 2025-02-27 | $122.41M derived: sum of 3 quarters · filed 2025-02-27 | $150.46M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $42.05M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $82.30M derived: sum of 2 quarters · filed 2025-02-27 | $110.35M derived: sum of 3 quarters · filed 2025-02-27 | $139.15M 10-K · filed 2025-02-27 |
| 2022-09-30 | $40.24M 10-Q · filed 2023-11-02 | $68.29M derived: sum of 2 quarters · filed 2023-11-02 | $97.09M 10-Q · filed 2023-11-02 | $129.11M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $28.05M 10-Q · filed 2023-08-03 | $56.85M 10-Q · filed 2023-08-03 | $88.87M derived: sum of 3 quarters · filed 2024-02-28 | $114.65M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $28.80M 10-Q · filed 2023-05-11 | $60.82M derived: sum of 2 quarters · filed 2024-02-28 | $86.60M derived: sum of 3 quarters · filed 2024-02-28 | $115.60M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $32.02M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $57.80M derived: sum of 2 quarters · filed 2024-02-28 | $86.80M derived: sum of 3 quarters · filed 2024-02-28 | $115.39M 10-K · filed 2024-02-28 |
| 2021-09-30 | $25.78M 10-Q · filed 2022-11-07 | $54.78M derived: sum of 2 quarters · filed 2022-11-07 | $83.37M 10-Q · filed 2022-11-07 | $106.69M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-06-30 | $29.00M 10-Q · filed 2022-08-11 | $57.59M 10-Q · filed 2022-08-11 | $80.90M derived: sum of 3 quarters · filed 2023-03-16 | $101.03M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-03-31 | $28.59M 10-Q · filed 2022-05-09 | $51.91M derived: sum of 2 quarters · filed 2023-03-16 | $72.03M derived: sum of 3 quarters · filed 2023-03-16 | $88.83M derived: sum of 4 quarters · filed 2023-03-16 |
| 2020-12-31 | $23.32M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $43.44M derived: sum of 2 quarters · filed 2023-03-16 | $60.24M derived: sum of 3 quarters · filed 2023-03-16 | $77.17M 10-K · filed 2023-03-16 |
| 2020-09-30 | $20.12M 10-Q · filed 2021-11-09 | $36.93M derived: sum of 2 quarters · filed 2021-11-09 | $53.85M 10-Q · filed 2021-11-09 | $84.03M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $16.80M 10-Q · filed 2021-08-16 | $33.73M 10-Q · filed 2021-08-16 | $63.91M derived: sum of 3 quarters · filed 2021-08-16 | $80.01M derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $16.92M 10-Q · filed 2021-05-10 | $47.10M derived: sum of 2 quarters · filed 2021-05-10 | $63.20M derived: sum of 3 quarters · filed 2021-05-10 | $78.53M derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $30.18M 10-K · filed 2020-03-12 | $46.28M derived: sum of 2 quarters · filed 2020-11-05 | $61.61M derived: sum of 3 quarters · filed 2020-11-05 | $72.97M 10-K · filed 2022-03-10 |
| 2019-09-30 | $16.10M 10-Q · filed 2020-11-05 | $31.43M derived: sum of 2 quarters · filed 2020-11-05 | $42.79M 10-Q · filed 2020-11-05 | $52.75M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $15.32M 10-Q · filed 2020-08-06 | $26.68M 10-Q · filed 2020-08-06 | $36.65M derived: sum of 3 quarters · filed 2020-08-06 | $43.62M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $11.36M 10-Q · filed 2020-05-28 | $21.32M derived: sum of 2 quarters · filed 2020-05-28 | $28.29M derived: sum of 3 quarters · filed 2020-05-28 | $35.74M derived: sum of 4 quarters · filed 2020-05-28 |
| 2018-12-31 | $9.96M 10-K · filed 2020-03-12 | $16.93M derived: sum of 2 quarters · filed 2020-03-12 | $24.38M derived: sum of 3 quarters · filed 2020-03-12 | $32.14M 10-K · filed 2021-03-11 |
| 2018-09-30 | $6.97M 10-K · filed 2020-03-12 | $14.42M derived: sum of 2 quarters · filed 2020-03-12 | $22.18M 10-Q · filed 2019-11-06 | $30.15M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $7.45M 10-K · filed 2020-03-12 | $15.21M 10-Q · filed 2019-08-01 | $23.18M derived: sum of 3 quarters · filed 2020-03-12 | $30.59M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $7.75M 10-K · filed 2020-03-12 | $15.73M derived: sum of 2 quarters · filed 2020-03-12 | $23.14M derived: sum of 3 quarters · filed 2020-03-12 | $30.04M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $7.98M 10-K · filed 2019-03-07 | $15.38M derived: sum of 2 quarters · filed 2019-03-07 | $22.29M derived: sum of 3 quarters · filed 2019-03-07 | $30.32M 10-K · filed 2020-03-12 |
| 2017-09-30 | $7.41M 10-K · filed 2019-03-07 | $14.31M derived: sum of 2 quarters · filed 2019-03-07 | $22.34M 10-Q · filed 2018-11-01 | $31.22M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | $6.91M 10-K · filed 2019-03-07 | $14.94M 10-Q · filed 2018-07-31 | $23.81M derived: sum of 3 quarters · filed 2019-03-07 | $32.80M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | $8.03M 10-K · filed 2019-03-07 | $16.91M derived: sum of 2 quarters · filed 2019-03-07 | $25.89M derived: sum of 3 quarters · filed 2019-03-07 | $35.01M derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | $8.88M 10-K · filed 2018-03-16 | $17.86M derived: sum of 2 quarters · filed 2018-03-16 | $26.98M derived: sum of 3 quarters · filed 2018-03-16 | $36.81M 10-K · filed 2019-03-07 |
| 2016-09-30 | $8.98M 10-K · filed 2018-03-16 | $18.11M derived: sum of 2 quarters · filed 2018-03-16 | $27.93M 10-Q · filed 2017-11-01 | $36.80M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-06-30 | $9.12M 10-K · filed 2018-03-16 | $18.95M 10-Q · filed 2017-08-09 | $27.81M derived: sum of 3 quarters · filed 2018-03-16 | $36.16M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-03-31 | $9.83M 10-K · filed 2018-03-16 | $18.69M derived: sum of 2 quarters · filed 2018-03-16 | $27.03M derived: sum of 3 quarters · filed 2018-03-16 | $36.76M derived: sum of 4 quarters · filed 2018-03-16 |
| 2015-12-31 | $8.86M 10-K · filed 2017-03-01 | $17.21M derived: sum of 2 quarters · filed 2017-03-01 | $26.94M derived: sum of 3 quarters · filed 2017-03-01 | $36.93M 10-K · filed 2018-03-16 |
| 2015-09-30 | $8.34M 10-K · filed 2017-03-01 | $18.07M derived: sum of 2 quarters · filed 2017-03-01 | $28.07M 10-Q · filed 2016-11-03 | $37.26M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $9.73M 10-K · filed 2017-03-01 | $19.72M 10-Q · filed 2016-08-03 | $28.91M derived: sum of 3 quarters · filed 2017-03-01 | $38.98M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $9.99M 10-K · filed 2017-03-01 | $19.18M derived: sum of 2 quarters · filed 2017-03-01 | $29.25M derived: sum of 3 quarters · filed 2017-03-01 | $38.25M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $9.19M 10-K · filed 2016-03-10 | $19.26M derived: sum of 2 quarters · filed 2016-03-10 | $28.26M derived: sum of 3 quarters · filed 2016-03-10 | $37.47M 10-K · filed 2017-03-01 |
| 2014-09-30 | $10.07M 10-K · filed 2016-03-10 | $19.07M derived: sum of 2 quarters · filed 2016-03-10 | $28.28M 10-Q · filed 2015-11-05 | $37.78M derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-06-30 | $9.00M 10-K · filed 2016-03-10 | $18.21M 10-Q · filed 2015-08-05 | $27.71M derived: sum of 3 quarters · filed 2016-03-10 | $36.62M derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-03-31 | $9.21M 10-K · filed 2016-03-10 | $18.70M derived: sum of 2 quarters · filed 2016-03-10 | $27.62M derived: sum of 3 quarters · filed 2016-03-10 | $36.70M derived: sum of 4 quarters · filed 2016-03-10 |
| 2013-12-31 | $9.50M 10-K · filed 2015-03-11 | $18.41M derived: sum of 2 quarters · filed 2015-03-11 | $27.49M derived: sum of 3 quarters · filed 2015-03-11 | $40.24M 10-K · filed 2016-03-10 |
| 2013-09-30 | $8.91M 10-K · filed 2015-03-11 | $17.99M derived: sum of 2 quarters · filed 2015-03-11 | $30.74M 10-Q · filed 2014-11-05 | $49.91M derived: sum of 4 quarters · filed 2015-03-11 |
| 2013-06-30 | $9.08M 10-K · filed 2015-03-11 | $21.83M 10-Q · filed 2014-08-11 | $41.00M derived: sum of 3 quarters · filed 2015-03-11 | $57.51M derived: sum of 4 quarters · filed 2015-03-11 |
| 2013-03-31 | $12.75M 10-K · filed 2015-03-11 | $31.92M derived: sum of 2 quarters · filed 2015-03-11 | $48.44M derived: sum of 3 quarters · filed 2015-03-11 | $67.05M derived: sum of 4 quarters · filed 2015-03-11 |
| 2012-12-31 | $19.17M 10-K · filed 2014-03-17 | $35.69M derived: sum of 2 quarters · filed 2014-03-17 | $54.30M derived: sum of 3 quarters · filed 2014-03-17 | $74.47M 10-K · filed 2015-03-11 |
| 2012-09-30 | $16.51M 10-K · filed 2014-03-17 | $35.12M derived: sum of 2 quarters · filed 2014-03-17 | $55.29M 10-Q · filed 2013-11-07 | $85.95M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-06-30 | $18.61M 10-K · filed 2014-03-17 | $38.78M 10-Q · filed 2013-08-08 | $69.44M derived: sum of 3 quarters · filed 2014-03-17 | $89.60M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-03-31 | $20.17M 10-K · filed 2014-03-17 | $50.83M derived: sum of 2 quarters · filed 2014-03-17 | $70.99M derived: sum of 3 quarters · filed 2014-03-17 | $92.86M derived: sum of 4 quarters · filed 2014-03-17 |
| 2011-12-31 | $30.66M 10-K · filed 2013-03-15 | $50.81M derived: sum of 2 quarters · filed 2013-03-15 | $72.69M derived: sum of 3 quarters · filed 2013-03-15 | $98.55M 10-K · filed 2014-03-17 |
| 2011-09-30 | $20.16M 10-K · filed 2013-03-15 | $42.03M derived: sum of 2 quarters · filed 2013-03-15 | $67.89M 10-Q · filed 2012-11-02 | $128.60M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-06-30 | $21.88M 10-K · filed 2013-03-15 | $47.74M 10-Q · filed 2012-08-03 | $108.45M derived: sum of 3 quarters · filed 2013-03-15 | $127.20M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-03-31 | $25.86M 10-K · filed 2013-03-15 | $86.57M derived: sum of 2 quarters · filed 2013-03-15 | $105.32M derived: sum of 3 quarters · filed 2013-03-15 | $123.20M derived: sum of 4 quarters · filed 2013-03-15 |
| 2010-12-31 | $60.71M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $79.46M derived: sum of 2 quarters · filed 2013-03-15 | $97.33M derived: sum of 3 quarters · filed 2013-03-15 | $114.73M 10-K · filed 2013-03-15 |
| 2010-09-30 | $18.75M 10-Q · filed 2011-11-03 | $36.63M derived: sum of 2 quarters · filed 2011-11-03 | $54.02M 10-Q · filed 2011-11-03 | |
| 2010-06-30 | $17.88M 10-Q · filed 2011-08-05 | $35.27M 10-Q · filed 2011-08-05 | ||
| 2009-12-31 | $71.96M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |